BOLD BlogNews and views from Cavidi

Keep in touch

Join our mailing list to receive new information relating to biomarker discovery and detection.

Exazym®: New Detection Limits Open New Possibilities

Exazym® — Pixels to Proteins

Exazym® — Ultra-Sensitivity Meets Practicality

Exazym® — A Breakthrough in Precision Health

Swedish health care delegation visit to India

Delhi, India. Cavidi CEO, John Reisky de Dubnic (left) joined a ...

Continue reading

”Getting to Zero” will require more than funding to succeed

On one hand we have last week’s report from the Join...

Continue reading

The HIV Subtype Picture

If you live in the West, you might be a little surprised by the ...

Continue reading

Three reasons HIV viral load monitoring matters

1. Patients. First and foremost, viral load monitoring (VLM) hel...

Continue reading

Honorable recognition of Cavidi Scientific Advisor

Professor Crowe has been at the forefront of HIV research in her...

Continue reading

Cavidi brings its message to AIDS 2010 in Vienna

Cavidi is attending the AIDS 2010 conference in Vienna to spread...

Continue reading

Helping HIV patients get the best possible treatment

More than half of the world’s population lives in settings tha...

Continue reading
Close Menu
×
×

Cart